(VIANEWS) – Ameresco (AMRC), Tidewater (TDW), Option Care Health (OPCH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ameresco (AMRC)
32.9% sales growth and 5.86% return on equity
Ameresco, Inc. provides comprehensive energy services for businesses and organizations in North America and Europe. It offers energy efficiency, infrastructure upgrades, energy security and resilience, asset sustainability, and renewable energy solutions. The company operates through U.S. Regions, U.S. Federal, Canada, and Non-Solar Distributed Generation segments. It designs, develops, engineers, and installs projects that reduce the energy, as well as operations and maintenance costs of customers' facilities. The company's projects primarily include various measures customized for the facility and designed to enhance the efficiency of building systems, such as heating, ventilation, cooling, and lighting systems. It also offers renewable energy products and services, such as the construction of small-scale plants for customers that produce electricity, gas, heat, or cooling from renewable sources of energy; and sells electricity and processed renewable gas fuel, heat, or cooling. In addition, the company provides integrated- photovoltaic (PV) and consulting, and enterprise energy management services; sells solar PV energy products and systems; and owns and operates a wind power project located in County Kerry, Ireland. It serves federal, state, and local governments, as well as healthcare and educational institutions, housing authorities, and commercial and industrial customers. As of December 31, 2019, the company owned and operated 99 small-scale renewable energy plants and solar PV installations. Ameresco, Inc. was founded in 2000 and is headquartered in Framingham, Massachusetts.
Earnings Per Share
As for profitability, Ameresco has a trailing twelve months EPS of $1.09.
PE Ratio
Ameresco has a trailing twelve months price to earnings ratio of 23.85. Meaning, the purchaser of the share is investing $23.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.86%.
Sales Growth
Ameresco’s sales growth is 15.8% for the current quarter and 32.9% for the next.
Yearly Top and Bottom Value
Ameresco’s stock is valued at $26.00 at 16:22 EST, way below its 52-week high of $63.19 and way above its 52-week low of $17.55.
Volume
Today’s last reported volume for Ameresco is 401180 which is 20.29% below its average volume of 503345.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 66.7% and 22.5%, respectively.
2. Tidewater (TDW)
27.7% sales growth and 13.64% return on equity
Tidewater Inc., together with its subsidiaries, provides offshore support vessels and marine support services to the offshore energy industry through the operation of a fleet of marine service vessels worldwide. It provides services in support of offshore oil and gas exploration, field development, and production, as well as windfarm development and maintenance, including towing of and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workover, and production activities; offshore construction, and seismic and subsea support; geotechnical survey support for windfarm construction; and various specialized services, such as pipe and cable laying. The company operates anchor handling towing supply vessels, platform supply vessels, crew boats, utility vessels, and offshore tugs. The company serves integrated and independent oil and gas exploration, field development, and production companies; mid-sized and smaller independent exploration and production companies; foreign government-owned or government-controlled organizations, and other related companies; offshore drilling contractors; and other companies, such as offshore construction, windfarm development, diving, and well stimulation companies. Tidewater Inc. was incorporated in 1956 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Tidewater has a trailing twelve months EPS of $2.52.
PE Ratio
Tidewater has a trailing twelve months price to earnings ratio of 37.35. Meaning, the purchaser of the share is investing $37.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.64%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 111.6% and 222.4%, respectively.
Moving Average
Tidewater’s worth is under its 50-day moving average of $99.55 and way above its 200-day moving average of $79.16.
Sales Growth
Tidewater’s sales growth is 53.6% for the current quarter and 27.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 66.3%, now sitting on 1.14B for the twelve trailing months.
3. Option Care Health (OPCH)
9.9% sales growth and 19.62% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.53.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 18.1. Meaning, the purchaser of the share is investing $18.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.62%.
Volume
Today’s last reported volume for Option Care Health is 4484860 which is 213.37% above its average volume of 1431130.
Moving Average
Option Care Health’s value is under its 50-day moving average of $29.36 and way below its 200-day moving average of $31.14.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $27.70 at 16:22 EST, way under its 52-week high of $35.74 and above its 52-week low of $26.17.
Sales Growth
Option Care Health’s sales growth is 9.5% for the ongoing quarter and 9.9% for the next.
4. CBOE Holdings (CBOE)
8.2% sales growth and 21.09% return on equity
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, Europe and Asia Pacific, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities. This segment also offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The Europe and Asia Pacific segment offers pan-European listed equities and derivatives transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, CBOE Holdings has a trailing twelve months EPS of $7.45.
PE Ratio
CBOE Holdings has a trailing twelve months price to earnings ratio of 22.74. Meaning, the purchaser of the share is investing $22.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.09%.
Yearly Top and Bottom Value
CBOE Holdings’s stock is valued at $169.40 at 16:22 EST, way under its 52-week high of $199.00 and way higher than its 52-week low of $133.02.
